688575.SS SHH
Shenzhen YHLO Biotech Co., Ltd.
1W: +0.9%
1M: +2.5%
3M: +14.8%
YTD: -22.9%
1Y: -33.1%
3Y: -43.5%
5Y: -65.2%
¥10.53 ($1.57)
+0.23 (+2.23%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$530M
+824.0% ▲
5Y CAGR: +50.6%
Capital Expenditures
$593M
+10.5% ▲
5Y CAGR: +35.9%
Free Cash Flow
-$63M
+91.4% ▲
Dividends Paid
$169M
+33.9% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$44M
+93.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $208M | $204M | $1.0B | $279M | $272M |
| Depreciation & Amort. | $70M | $99M | $145M | $197M | $247M |
| Stock-Based Comp. | $0 | $0 | $21M | $0 | $0 |
| Change in Working Capital | -$28M | -$82M | $295M | -$570M | -$93M |
| Other Non-Cash Items | $33M | $38M | $118M | $34M | $103M |
| Operating Cash Flow | $282M | $260M | $1.6B | -$64M | $530M |
| — Investing Activities — | |||||
| Capital Expenditures | -$189M | -$373M | -$565M | -$663M | -$593M |
| Acquisitions (Net) | $209K | $5M | -$6M | $19M | -$26K |
| Investment Purchases | -$209K | -$637M | -$774M | -$240M | -$368M |
| Investment Sales | $20M | $548M | $498M | $272M | $213M |
| Other Investing | $1M | -$5M | -$22M | $9M | $23K |
| Investing Cash Flow | -$168M | -$461M | -$870M | -$604M | -$749M |
| — Financing Activities — | |||||
| Net Debt Issuance | $30M | -$86M | $234M | $252M | $344M |
| Stock Repurchased | $5M | $0 | $0 | $0 | $0 |
| Dividends Paid | -$22M | -$11M | -$162M | -$256M | -$169M |
| Other Financing | $2M | $545M | -$58M | -$56M | $5M |
| Financing Cash Flow | -$9M | $448M | $13M | -$60M | $181M |
| Net Change in Cash | $103M | $245M | $737M | -$723M | -$44M |
| Cash End of Period | $229M | $474M | $1.2B | $488M | $444M |
| Free Cash Flow | $93M | -$113M | $1.0B | -$736M | -$63M |